Published in Vaccine Weekly, May 10th, 2006
Study 1: Vaccination with a cytotoxic T-lymphocyte epitope protects against human metapneumovirus infection and disease in mice.
According to recent research from Australia, "Human metapneumovirus (hMPV) has emerged as an important human respiratory pathogen causing upper and lower respiratory tract infections in young children and older adults. In addition, hMPV infection is associated with asthma exacerbation in young children. Recent epidemiological evidence indicates that hMPV may co-circulate with human respiratory syncytial virus (hRSV) and mediate clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.